83 related articles for article (PubMed ID: 454928)
1. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
Howlett DR; Morris H; Nahorski SR
Br J Pharmacol; 1979 May; 66(1):136P. PubMed ID: 454928
[No Abstract] [Full Text] [Related]
2. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
Howlett DR; Nahorski SR
Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752
[No Abstract] [Full Text] [Related]
3. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
Clements-Jewery S; Robson PA
Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
[No Abstract] [Full Text] [Related]
4. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
Lai HC; Carino MA; Horita A
Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
[No Abstract] [Full Text] [Related]
5. Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.
Howlett DR; Morris H; Nahorski SR
Mol Pharmacol; 1979 May; 15(3):506-14. PubMed ID: 492143
[No Abstract] [Full Text] [Related]
6. [3H]spiperone binding sites in rat primary glial cultures, C6 glioma, and B104 neuroblastoma.
Severson JA; de Vellis JS; Finch CE
J Neurosci Res; 1983; 9(1):21-6. PubMed ID: 6834436
[TBL] [Abstract][Full Text] [Related]
7. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
8. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites.
Fuxe K; Agnati LF; Benfenati F; Cimmino M; Algeri S; Hökfelt T; Mutt V
Acta Physiol Scand; 1981 Dec; 113(4):567-9. PubMed ID: 6291324
[No Abstract] [Full Text] [Related]
9. Two binding sites for 3H-spiroperidol on rat striatal membranes.
Briley M; Langer SZ
Eur J Pharmacol; 1978 Aug; 50(3):283-4. PubMed ID: 28956
[No Abstract] [Full Text] [Related]
10. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum.
Hennies HH; Hess V; Flohé L
Arzneimittelforschung; 1984; 34(11):1481-4. PubMed ID: 6543122
[TBL] [Abstract][Full Text] [Related]
11. Lisuride inhibits 3H-spiroperidol binding to membranes isolated from striatum.
Fujita N; Saito K; Yonehara N; Yoshida H
Neuropharmacology; 1978 Dec; 17(12):1089-91. PubMed ID: 745698
[No Abstract] [Full Text] [Related]
12. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
Noguchi-kuno SA; Nakata C; Nishitani H
Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
[No Abstract] [Full Text] [Related]
13. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
Zahniser NR; Molinoff PB
Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
[TBL] [Abstract][Full Text] [Related]
14. Change in the charactertistics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: effects of buffer washing of membranes.
Owen F; Cross AJ; Poulter M; Waddington JL
Life Sci; 1979 Jul; 25(4):385-90. PubMed ID: 38372
[No Abstract] [Full Text] [Related]
15. Chronic sulpiride increased 3H-spiperone binding and calmodulin dependent phosphorylation in rat striatum.
Lau YS; Runice C; Dowd FJ; Anene C
Proc West Pharmacol Soc; 1983; 26():139-43. PubMed ID: 6310625
[No Abstract] [Full Text] [Related]
16. The in vivo and in vitro occupation of [3H]-spiperone binding sites in the frontal cortex and striatum by putative 5-hydroxytryptamine antagonists.
Clements-Jewery S; Robson PA
Neuropharmacology; 1980 Jul; 19(7):657-61. PubMed ID: 7402453
[No Abstract] [Full Text] [Related]
17. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain.
Pedigo NW; Reisine TD; Fields JZ; Yamamura HI
Eur J Pharmacol; 1978 Aug; 50(4):451-3. PubMed ID: 699968
[No Abstract] [Full Text] [Related]
18. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
Agnati LF; Fuxe K; Battistini N; Benfenati F
Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074
[No Abstract] [Full Text] [Related]
19. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
